220 related articles for article (PubMed ID: 27699227)
1. Elimination of p19
Hashimoto M; Asai A; Kawagishi H; Mikawa R; Iwashita Y; Kanayama K; Sugimoto K; Sato T; Maruyama M; Sugimoto M
JCI Insight; 2016 Aug; 1(12):e87732. PubMed ID: 27699227
[TBL] [Abstract][Full Text] [Related]
2. Elimination of p19
Mikawa R; Suzuki Y; Baskoro H; Kanayama K; Sugimoto K; Sato T; Sugimoto M
Aging Cell; 2018 Oct; 17(5):e12827. PubMed ID: 30058137
[TBL] [Abstract][Full Text] [Related]
3. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
[TBL] [Abstract][Full Text] [Related]
4. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
Haviernik P; Schmidt M; Hu X; Wolff L
Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
[TBL] [Abstract][Full Text] [Related]
5. p19
Mikawa R; Sato T; Suzuki Y; Baskoro H; Kawaguchi K; Sugimoto M
Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32192082
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of senescent cell formation and retention revealed by p14ARF induction in the epidermis.
Tokarsky-Amiel R; Azazmeh N; Helman A; Stein Y; Hassan A; Maly A; Ben-Porath I
Cancer Res; 2013 May; 73(9):2829-39. PubMed ID: 23423975
[TBL] [Abstract][Full Text] [Related]
7. p16Ink4a or p19Arf loss contributes to Tal1-induced leukemogenesis in mice.
Shank-Calvo JA; Draheim K; Bhasin M; Kelliher MA
Oncogene; 2006 May; 25(21):3023-31. PubMed ID: 16407836
[TBL] [Abstract][Full Text] [Related]
8. The yin and yang of the Cdkn2a locus in senescence and aging.
Baker DJ; Jin F; van Deursen JM
Cell Cycle; 2008 Sep; 7(18):2795-802. PubMed ID: 18769141
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of p19(Arf) and p16(Ink4a) loss on senescence of murine bone marrow-derived preB cells and macrophages.
Randle DH; Zindy F; Sherr CJ; Roussel MF
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9654-9. PubMed ID: 11481442
[TBL] [Abstract][Full Text] [Related]
10. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
[TBL] [Abstract][Full Text] [Related]
11. Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency.
Baker DJ; Perez-Terzic C; Jin F; Pitel KS; Niederländer NJ; Jeganathan K; Yamada S; Reyes S; Rowe L; Hiddinga HJ; Eberhardt NL; Terzic A; van Deursen JM
Nat Cell Biol; 2008 Jul; 10(7):825-36. PubMed ID: 18516091
[TBL] [Abstract][Full Text] [Related]
12. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
Shin J; Yang J; Lee JC; Baek KH
Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
[TBL] [Abstract][Full Text] [Related]
13. p19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathways.
Kelly-Spratt KS; Gurley KE; Yasui Y; Kemp CJ
PLoS Biol; 2004 Aug; 2(8):E242. PubMed ID: 15314658
[TBL] [Abstract][Full Text] [Related]
14. Induction of p16ink4a and p19ARF by TGFbeta1 contributes to growth arrest and senescence response in mouse keratinocytes.
Vijayachandra K; Higgins W; Lee J; Glick A
Mol Carcinog; 2009 Mar; 48(3):181-186. PubMed ID: 18655107
[TBL] [Abstract][Full Text] [Related]
15. Efficiency alleles of the Pctr1 modifier locus for plasmacytoma susceptibility.
Zhang SL; DuBois W; Ramsay ES; Bliskovski V; Morse HC; Taddesse-Heath L; Vass WC; DePinho RA; Mock BA
Mol Cell Biol; 2001 Jan; 21(1):310-8. PubMed ID: 11113205
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the INK4a/Arf gene locus in senescence.
Collins CJ; Sedivy JM
Aging Cell; 2003 Jun; 2(3):145-50. PubMed ID: 12882406
[TBL] [Abstract][Full Text] [Related]
17. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
[TBL] [Abstract][Full Text] [Related]
18. Loss of neurofibromatosis-1 and p19(ARF) cooperate to induce a multiple tumor phenotype.
King D; Yang G; Thompson MA; Hiebert SW
Oncogene; 2002 Jul; 21(32):4978-82. PubMed ID: 12118376
[TBL] [Abstract][Full Text] [Related]
19. An antioxidant suppressed lung cellular senescence and enhanced pulmonary function in aged mice.
Kawaguchi K; Hashimoto M; Sugimoto M
Biochem Biophys Res Commun; 2021 Feb; 541():43-49. PubMed ID: 33465741
[TBL] [Abstract][Full Text] [Related]
20. p19ARF determines the balance between normal cell proliferation rate and apoptosis during mammary gland development.
Yi Y; Shepard A; Kittrell F; Mulac-Jericevic B; Medina D; Said TK
Mol Biol Cell; 2004 May; 15(5):2302-11. PubMed ID: 15105443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
